These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 10894979)
1. Thromboangiitis obliterans: a rare cause of a reversible Raynaud's phenomenon. Noël B; Krayenbühl B; Cerottini JP; Guggisberg D; Buxtorf K; Pires A; Panizzon RG Dermatology; 2000; 200(4):363-5. PubMed ID: 10894979 [TBL] [Abstract][Full Text] [Related]
2. [A rare case of cannabis arteritis]. Gröger A; Aslani A; Wolter T; Noah EM; Pallua N Vasa; 2003 May; 32(2):95-7. PubMed ID: 12945103 [TBL] [Abstract][Full Text] [Related]
3. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170 [TBL] [Abstract][Full Text] [Related]
4. A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Torley HI; Madhok R; Capell HA; Brouwer RM; Maddison PJ; Black CM; Englert H; Dormandy JA; Watson HR Ann Rheum Dis; 1991 Nov; 50(11):800-4. PubMed ID: 1722967 [TBL] [Abstract][Full Text] [Related]
5. Iloprost treatment for refractory Raynaud's phenomenon in two infants. Shouval DS; Mukamel M; Zulian F; Amir J; Harel L Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S105-7. PubMed ID: 18799065 [TBL] [Abstract][Full Text] [Related]
6. Possibilities for clinical use of prostacyclin in vascular disease. Poredos P Pflugers Arch; 2000; 440(5 Suppl):R137-8. PubMed ID: 11005643 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of alprostadil and iloprost in digital necrosis due to secondary Raynaud's phenomenon. Lamprecht P; Schnabel A; Gross WL Br J Rheumatol; 1998 Jun; 37(6):703-4. PubMed ID: 9667634 [No Abstract] [Full Text] [Related]
8. [The neurovascular plexus of the fingers in Buerger's disease, in Raynaud's disease and in scleroderma]. CURRI SB Riv Anat Patol Oncol; 1961 Jun; 19():635-54. PubMed ID: 13882722 [No Abstract] [Full Text] [Related]
9. Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis. Pope J; Fenlon D; Thompson A; Shea B; Furst D; Wells G; Silman A Cochrane Database Syst Rev; 2000; 1998(2):CD000953. PubMed ID: 10796395 [TBL] [Abstract][Full Text] [Related]
10. [Raynaud's phenomenon--hand and finger asphyxia; dead or dying finger]. Lemmens HA Vasa; 1977; 6(3):295-9. PubMed ID: 919742 [No Abstract] [Full Text] [Related]
11. [Severe Raynaud's phenomenon associated with interferon-beta therapy for multiple sclerosis: case report]. Cruz BA; Queiroz ED; Nunes SV; Cruz Filho A; Campos GB; Monteiro EL; Crivellari H Arq Neuropsiquiatr; 2000 Jun; 58(2B):556-9. PubMed ID: 10920422 [TBL] [Abstract][Full Text] [Related]
12. [Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis]. Cordioli E; Virgilio S; Ghirardi R; Martinelli M Minerva Med; 1992 Nov; 83(11):739-44. PubMed ID: 1281297 [TBL] [Abstract][Full Text] [Related]
13. [The place of Raynaud's phenomenon in arterial diseases of the upper limb]. van der Stricht J; Goldstein M; Dereume JP Schweiz Rundsch Med Prax; 1976 Nov; 65(44):1365-7. PubMed ID: 1005331 [No Abstract] [Full Text] [Related]
14. Is iloprost effective in secondary Raynaud's phenomenon? Lustig N; Rada G Medwave; 2015 Mar; 15(2):e6082. PubMed ID: 25826330 [TBL] [Abstract][Full Text] [Related]
15. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis]. Serri J; Legré R; Veit V; Guardia C; Gay AM Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894 [TBL] [Abstract][Full Text] [Related]
16. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma. Colakoğlu M; Cobankara V; Akpolat T Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574 [TBL] [Abstract][Full Text] [Related]
17. Severe digital necrosis in a 4-year-old boy: primary Raynaud's or jellyfish sting. Binnetoglu FK; Kizildag B; Topaloglu N; Kasapcopur O BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24248320 [TBL] [Abstract][Full Text] [Related]
18. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test]. Cristol R; Debray J J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527 [TBL] [Abstract][Full Text] [Related]
19. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol. Milio G; Corrado E; Genova C; Amato C; Raimondi F; Almasio PL; Novo S Rheumatology (Oxford); 2006 Aug; 45(8):999-1004. PubMed ID: 16484290 [TBL] [Abstract][Full Text] [Related]